Bufei huoxue capsule alleviates bleomycin-induced pulmonary fibrosis in mice via TGF-β1/Smad2/3 signaling
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangdong Province
Inner Mongolia Medical University
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference35 articles.
1. Study on the mechanism of Astragalus polysaccharide in treating pulmonary fibrosis based on "Drug-Target-Pathway" network;Bing;Front. Pharmacol.,2022
2. Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial;Chen;Pulm. Circ.,2021
3. Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: a multicentre, double-blind, and randomised controlled trial;Chen;J. Ethnopharmacol.,2022
4. Protective effects of pretreatment with Radix Paeoniae Rubra on acute lung injury induced by intestinal ischemia/reperfusion in rats;Chen;Chin. J. Traumatol.,2008
5. Developmental pathways in the pathogenesis of lung fibrosis;Chanda;Mol. Aspect. Med.,2019
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Histone deacetylase 6 controls cardiac fibrosis and remodelling through the modulation of TGF‐β1/Smad2/3 signalling in post‐infarction mice;Journal of Cellular and Molecular Medicine;2024-09
2. Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis;Immunity, Inflammation and Disease;2024-08
3. Bufei Huoxue capsule attenuates COPD-related inflammation and regulates intestinal microflora, metabolites;Frontiers in Pharmacology;2024-04-09
4. Advances in the application of traditional Chinese medicine during the COVID-19 recovery period: A review;Medicine;2024-04-05
5. AP39 through AMPK-ULK1-FUNDC1 pathway regulates mitophagy, inhibits pyroptosis, and improves doxorubicin-induced myocardial fibrosis;iScience;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3